CIC Market Solutions recommends purchasing ABIONYX Pharma shares

Toulouse, France and Lakeland, MI, USA, March 21, 2025 – ABIONYX Pharma, a company specializing in innovative biomedicines, announces that CIC Market Solutions has initiated coverage of its stock with a Buy recommendation. This initiative by CIC Market Solutions, part of the Crédit Mutuel Alliance Fédérale group, marks an important step for ABIONYX, giving it greater visibility in the European financial market.

CIC Market Solutions, a major financial services company, published an initiation study on March 20, 2025, highlighting the company's positive outlook. ABIONYX develops treatments based on recombinant apolipoprotein apoA-I targeting severe inflammatory diseases, innovating in a field with limited treatments. This progress reflects ABIONYX's commitment to developing cutting-edge medical solutions.